Baird Capital Invests in Upfront Healthcare

Baird Capital Invests $53M in EvoluteIQ

September 17, 2025

AI & Machine Learning

Baird Capital has made a $53 million growth investment in EvoluteIQ, an AI-native platform that automates end-to-end business processes. The funding will be used to accelerate EvoluteIQ's global expansion and scale its enterprise agentic AI capabilities across industries including banking, insurance, healthcare, telecom and manufacturing.

Health Catalyst Signs Definitive Agreement to Acquire Upfront Healthcare Services

January 13, 2025

Data & Analytics

Health Catalyst (Nasdaq: HCAT) has signed a definitive agreement to acquire Upfront Healthcare Services, a patient engagement and activation platform provider. The company expects the transaction to close in the first quarter of 2025 and plans to fund it with a mix of cash and stock.

Baird Capital Makes Growth Investment in Freemarket

May 23, 2023

Payments & Fintech

Baird Capital’s Global Private Equity Fund has made a growth capital investment in Freemarket, a London-based fintech that provides B2B cross-border payments and currency exchange. The funding will support Freemarket’s international expansion and fast growth while providing a partial cash-out to existing shareholders; financial terms were not disclosed.

Upfront Healthcare Acquires PatientBond

August 18, 2022

Healthcare Services

Upfront, a Baird Capital-backed patient engagement and access platform, has acquired PatientBond, a consumer-science leader in healthcare. The deal combines PatientBond’s psychographic segmentation and consumer insights with Upfront’s omnichannel engagement platform to expand personalization and patient activation capabilities across health systems, urgent care, payers, and life sciences customers.

Baird Capital Invests in HSP Group

December 3, 2020

Professional Services

Baird Capital has made a growth investment in HSP Group, a technology-enabled business services firm that provides finance, tax, legal and HR support to companies expanding internationally. The capital will help HSP Group launch and accelerate its operations and expand its service offerings across the US and Europe.

Baird Capital Invests in Blue Matter Consulting

September 1, 2020

Healthcare Services

Baird Capital, the private investment arm of Robert W. Baird & Co., has made a growth investment in Blue Matter Consulting LLC, a life sciences strategy consulting firm. The capital will support Blue Matter’s growth plans, including accelerating organic expansion and enabling potential strategic acquisitions; financial terms were not disclosed.